Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H R Roberts

Showing results (101-110 of 182) with videos related to

Pageof 19
Sort By:
Thrombosis Research|October 1, 1975
Effect of lysosomal cationic proteins from polymorphonuclear leukocytes upon the fibrinogen and fibrinolysis systemH I Saba, J C Herion, R I Walker, et al.
Lancet (London, England)|June 3, 1978
Antithrombin-III transfusion in disseminated intravascular coagulationP M Blatt, G C White, J C Goldsmith, et al.
The Journal of Laboratory and Clinical Medicine|March 1, 1986
Granulocyte lysosomal cationic protein alters fibrin assembly: a possible mechanism for granulocyte control of clot structureM E Carr, D A Gabriel, J C Herion, et al.
Annals of the New York Academy of Sciences|January 1, 1981
The platelet membrane as a catalytic surface in thrombin generation: availability of platelet factor 1 and platelet factor 3A P Bode, F A Dombrose, B R Lentz, et al.
Biochemistry|February 18, 1992
The endothelial cell binding determinant of human factor IX resides in the gamma-carboxyglutamic acid domainJ R Toomey, K J Smith, H R Roberts, et al.
Thrombosis and Haemostasis|February 12, 1999
TFPIbeta, a second product from the mouse tissue factor pathway inhibitor (TFPI) geneJ Y Chang, D M Monroe, J A Oliver, et al.
Blood|July 1, 1983
Treatment of a high titer anti-factor-VIII antibody by continuous factor VIII administration: report of a caseG C White, R E Taylor, P M Blatt, et al.
The Journal of Biological Chemistry|June 25, 1990
Characterization of the functional defect in factor IX Alabama. Evidence for a conformational change due to high affinity calcium binding in the first epidermal growth factor domainD M McCord, D M Monroe, K J Smith, et al.
American Journal of Hematology|December 1, 1982
Factor VIII inhibitors: a clinical overviewG C White, C W McMillan, P M Blatt, et al.
Progress in Clinical and Biological Research|January 1, 1981
Structural abnormalities of the vitamin K-dependent clotting factorsH R Roberts, M J Griffith, K M Braunstein, et al.
Pageof 19

Showing results (101-110 of 182) with videos related to

Sort By:
Pageof 19
Thrombosis Research|October 1, 1975
Effect of lysosomal cationic proteins from polymorphonuclear leukocytes upon the fibrinogen and fibrinolysis systemH I Saba, J C Herion, R I Walker, et al.
Lancet (London, England)|June 3, 1978
Antithrombin-III transfusion in disseminated intravascular coagulationP M Blatt, G C White, J C Goldsmith, et al.
The Journal of Laboratory and Clinical Medicine|March 1, 1986
Granulocyte lysosomal cationic protein alters fibrin assembly: a possible mechanism for granulocyte control of clot structureM E Carr, D A Gabriel, J C Herion, et al.
Annals of the New York Academy of Sciences|January 1, 1981
The platelet membrane as a catalytic surface in thrombin generation: availability of platelet factor 1 and platelet factor 3A P Bode, F A Dombrose, B R Lentz, et al.
Biochemistry|February 18, 1992
The endothelial cell binding determinant of human factor IX resides in the gamma-carboxyglutamic acid domainJ R Toomey, K J Smith, H R Roberts, et al.
Thrombosis and Haemostasis|February 12, 1999
TFPIbeta, a second product from the mouse tissue factor pathway inhibitor (TFPI) geneJ Y Chang, D M Monroe, J A Oliver, et al.
Blood|July 1, 1983
Treatment of a high titer anti-factor-VIII antibody by continuous factor VIII administration: report of a caseG C White, R E Taylor, P M Blatt, et al.
The Journal of Biological Chemistry|June 25, 1990
Characterization of the functional defect in factor IX Alabama. Evidence for a conformational change due to high affinity calcium binding in the first epidermal growth factor domainD M McCord, D M Monroe, K J Smith, et al.
American Journal of Hematology|December 1, 1982
Factor VIII inhibitors: a clinical overviewG C White, C W McMillan, P M Blatt, et al.
Progress in Clinical and Biological Research|January 1, 1981
Structural abnormalities of the vitamin K-dependent clotting factorsH R Roberts, M J Griffith, K M Braunstein, et al.
Pageof 19